Literature DB >> 18083040

Perivascular tissue of internal thoracic artery releases potent nitric oxide and prostacyclin-independent anticontractile factor.

Marcin Malinowski1, Marek A Deja, Krzysztof S Gołba, Tomasz Roleder, Jolanta Biernat, Stanisław Woś.   

Abstract

OBJECTIVE: It has been recently suggested that perivascular tissue (PVT) releases hypothetic adipocyte- or adventitia-derived relaxing factor. The aim of the study was to assess anticontractile properties of perivascular tissue of human internal thoracic artery (ITA) and to check if this activity is nitric oxide (NO)- or prostacyclin-dependent. We also analyzed the influence of pleural adipose tissue on ITA reactivity.
METHODS: Human ITA rings were studied in vitro. First, skeletonized and pedicled ITA reactivity to serotonin and angiotensin II was compared. In subsequent experiments fragments of ITA were skeletonized and divided into two preparations. One was incubated alone, the other together with PVT or pleural adipose tissue floating freely in the bath. First, concentration-response curves to either serotonin or angiotensin II were constructed. Tissue was then transferred from one bath to the other and concentration-response curves were reconstructed. The same protocol was applied with the inhibition of NO synthase with L-NMMA (10(-4)M) and cyclooxygenase with indomethacin (10(-5)M).
RESULTS: Skeletonization augmented contractile response to serotonin (E(max) 16.6+/-1.85 mN vs 43.8+/-3.87 mN; pedicled vs skeletonized ITA, respectively; p<0.001) and angiotensin II (E(max) 10.9+/-1.07 mN vs 26.6+/-1.45 mN, respectively; p<0.001). PVT presence in the bath caused decrease of E(max) from 40.8+/-5.01 to 20.1+/-2.69 mN for serotonin; p<0.001 and from 31.4+/-3.75 to 13.0+/-1.60 mN for angiotensin II, p<0.001 (PVT(-) vs PVT(+), respectively). PVT did not change ITA sensitivity (EC(50)) to serotonin or angiotensin II. Pleural adipose tissue did not change the contractile response of ITA to serotonin (E(max) 37.2+/-4.95 mN vs 36.3+/-4.83 mN, pleural fat+and pleural fat-, respectively; p=0.9). NO and prostacyclin inhibition failed to abolish anticontractile properties of perivascular tissue. PVT with cyclooxygenase and NO synthase inhibition decreased E(max) of serotonin from 46.6+/-3.03 to 28.2+/-4.02 mN, p<0.001 and E(max) of angiotensin II from 27.2+/-2.00 to 16.4+/-2.10 mN, p<0.001.
CONCLUSIONS: Perivascular tissue of ITA releases potent, soluble, nitric oxide and prostacyclin-independent anticontractile factor. The pleural adipose tissue does not influence ITA reactivity to vasoconstrictors. Preservation of perivascular tissue may protect against vasospasm of ITA graft in clinical settings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18083040     DOI: 10.1016/j.ejcts.2007.11.007

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  24 in total

1.  Altered adipocyte progenitor population and adipose-related gene profile in adipose tissue by long-term high-fat diet in mice.

Authors:  Xiaohua Xu; Cuiqing Liu; Zhaobin Xu; Kevin Tzan; Aixia Wang; Sanjay Rajagopalan; Qinghua Sun
Journal:  Life Sci       Date:  2012-06-05       Impact factor: 5.037

2.  Lean and Obese Coronary Perivascular Adipose Tissue Impairs Vasodilation via Differential Inhibition of Vascular Smooth Muscle K+ Channels.

Authors:  Jillian N Noblet; Meredith K Owen; Adam G Goodwill; Daniel J Sassoon; Johnathan D Tune
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

Review 3.  Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target.

Authors:  Reza Aghamohammadzadeh; Sarah Withers; Fiona Lynch; Adam Greenstein; R Malik; Anthony Heagerty
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

4.  Sex differences in the regulation of porcine coronary artery tone by perivascular adipose tissue: a role of adiponectin?

Authors:  Abdulla A Ahmad; Michael D Randall; Richard E Roberts
Journal:  Br J Pharmacol       Date:  2017-07-12       Impact factor: 8.739

Review 5.  Modulation of Vascular Reactivity by Perivascular Adipose Tissue (PVAT).

Authors:  Claudia Agabiti-Rosei; Anna Paini; Carolina De Ciuceis; Sarah Withers; Adam Greenstein; Anthony M Heagerty; Damiano Rizzoni
Journal:  Curr Hypertens Rep       Date:  2018-05-07       Impact factor: 5.369

Review 6.  Perivascular adipose tissue: more than just structural support.

Authors:  Theodora Szasz; R Clinton Webb
Journal:  Clin Sci (Lond)       Date:  2012-01       Impact factor: 6.124

7.  Sex differences in the role of phospholipase A2 -dependent arachidonic acid pathway in the perivascular adipose tissue function in pigs.

Authors:  Abdulla A Ahmad; Michael D Randall; Richard E Roberts
Journal:  J Physiol       Date:  2017-09-24       Impact factor: 5.182

Review 8.  Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease.

Authors:  Gregory A Payne; Meredith C Kohr; Johnathan D Tune
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

9.  Influence of exercise and perivascular adipose tissue on coronary artery vasomotor function in a familial hypercholesterolemic porcine atherosclerosis model.

Authors:  Aaron K Bunker; M Harold Laughlin
Journal:  J Appl Physiol (1985)       Date:  2009-12-03

10.  Dahl SS rats demonstrate enhanced aortic perivascular adipose tissue-mediated buffering of vasoconstriction through activation of NOS in the endothelium.

Authors:  Frank T Spradley; Dao H Ho; Jennifer S Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-25       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.